2017 MIPS Measure #290: Parkinson’s Disease: Psychiatric Symptoms Assessment for Patients with Parkinson’s Disease

Valid Data Submission Method(s) Measure Type High Priority Measure? NQS Domain Specialty Measure Sets
Registry Process No Effective Clinical Care Neurology

Measure Description

All patients with a diagnosis of Parkinson’s disease who were assessed for psychiatric symptoms (e.g., psychosis, depression, anxiety disorder, apathy, or impulse control disorder) in the last 12 months

Instruction

This measure is to be reported a minimum of once per performance period for patients with a diagnosis of Parkinson’s disease seen during the performance period. This measure may be reported by eligible clinician who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

Denominator

All patients aged 18 years and older with a diagnosis of Parkinson’s disease

Denominator Criteria (Eligible Cases):
Patients aged ≥ 18 years on date of encounter
AND
Diagnosis for Parkinson’s disease (ICD-10-CM): G20
AND
Patient encounter during the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213,99214, 99215, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328,99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350
WITHOUT
Telehealth Modifier: GQ,GT

Numerator

Patients with a diagnosis of Parkinson’s disease who were assessed for psychiatric symptoms in the last 12 months (e.g., psychosis, depression, anxiety disorder, apathy, or impulse control disorder)

Numerator Options:
Performance Met: Psychiatric symptoms assessed (G9742)
OR
Performance Not Met: Psychiatric symptoms not assessed, reason not otherwise specified (G9743)

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.